BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36499093)

  • 21. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.
    Raimondi L; De Luca A; Morelli E; Giavaresi G; Tagliaferri P; Tassone P; Amodio N
    Biomed Res Int; 2016; 2016():6504593. PubMed ID: 26881223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.
    Berenstein R; Blau O; Nogai A; Waechter M; Slonova E; Schmidt-Hieber M; Kunitz A; Pezzutto A; Doerken B; Blau IW
    BMC Cancer; 2015 Feb; 15():68. PubMed ID: 25886144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing.
    Agnelli L; Bisognin A; Todoerti K; Manzoni M; Taiana E; Galletti S; Cutrona G; Gaffo E; Bortoluzzi S; Neri A
    Blood Cancer J; 2019 Feb; 9(3):21. PubMed ID: 30783080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of patients at high risk of secondary extramedullary multiple myeloma development.
    Stork M; Sevcikova S; Minarik J; Krhovska P; Radocha J; Pospisilova L; Brozova L; Jarkovsky J; Spicka I; Straub J; Pavlicek P; Jungova A; Jelinek T; Sandecka V; Maisnar V; Hajek R; Pour L
    Br J Haematol; 2022 Feb; 196(4):954-962. PubMed ID: 34726261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bioinformatics analysis of the microRNA expression profile in the peripheral blood lymphocytes of Kazakh patients with essential hypertension in Xinjiang].
    Wang Y; Zhang L; Yang R; Shan LY; Wang L; Zhang YY; Li XZ; Ma KT
    Sheng Li Xue Bao; 2022 Oct; 74(5):751-762. PubMed ID: 36319098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in urine as diagnostic biomarkers for multiple myeloma.
    Li J; Wang C; Meng Q; Hu Z; Hu M; Zhang M
    Int J Lab Hematol; 2021 Apr; 43(2):227-234. PubMed ID: 33068078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential miRNAs profile and bioinformatics analyses in bone marrow mesenchymal stem cells from adolescent idiopathic scoliosis patients.
    Hui S; Yang Y; Li J; Li N; Xu P; Li H; Zhang Y; Wang S; Lin G; Li S; Qiu G; Zhao RC; Zhang J; Zhuang Q
    Spine J; 2019 Sep; 19(9):1584-1596. PubMed ID: 31100472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis.
    Pourhanifeh MH; Mahjoubin-Tehran M; Shafiee A; Hajighadimi S; Moradizarmehri S; Mirzaei H; Asemi Z
    IUBMB Life; 2020 Mar; 72(3):314-333. PubMed ID: 31828868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
    Gupta N; Kumar R; Seth T; Garg B; Sharma A
    RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.
    Luo X; Gu J; Zhu R; Feng M; Zhu X; Li Y; Fei J
    BMC Syst Biol; 2014 Jul; 8():82. PubMed ID: 25000828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
    Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
    Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA miR-188-5p as a mediator of long non-coding RNA MALAT1 regulates cell proliferation and apoptosis in multiple myeloma.
    Liu H; Chi Z; Jin H; Yang W
    Bioengineered; 2021 Dec; 12(1):1611-1626. PubMed ID: 33944676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.
    Yin Y; Yang W; Zhang L; Liu K; Luo Z
    Hematology; 2021 Dec; 26(1):160-169. PubMed ID: 33528317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing.
    Wang F; Lu J; Peng X; Wang J; Liu X; Chen X; Jiang Y; Li X; Zhang B
    J Exp Clin Cancer Res; 2016 Jan; 35():17. PubMed ID: 26795575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.
    Garabet L; Ghanima W; Rangberg A; Teruel-Montoya R; Martinez C; Lozano ML; Nystrand CF; Bussel JB; Sandset PM; Jonassen CM
    Platelets; 2020; 31(2):198-205. PubMed ID: 30885035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical Analysis of 46 Cases of Multiple Myeloma with Extramedullary Disease].
    Chao Y; Fan L; Gao XY; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):115-121. PubMed ID: 33554807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
    Xu YY; Song YQ; Huang ZM; Zhang HB; Chen M
    Kaohsiung J Med Sci; 2019 May; 35(5):277-283. PubMed ID: 30897301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling.
    Tang B; Xu A; Xu J; Huang H; Chen L; Su Y; Zhang L; Li J; Fan F; Deng J; Tang L; Sun C; Hu Y
    Int J Cancer; 2018 Jan; 142(1):109-120. PubMed ID: 28905994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
    Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
    Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
    J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.